Chonluten for Bronchial & Lung Tissue Support — Bioregulators
Khavinson bioregulator peptide for pulmonary tissue regeneration and respiratory system optimization.
Overview
Chonluten is a Khavinson bioregulator peptide targeting bronchial and lung tissues for respiratory system support. Similar to Bronchogen but with potentially distinct peptide sequences, Chonluten works through DNA-level gene regulation to restore lung tissue function and support pulmonary health. It's used for chronic respiratory conditions, lung tissue repair, and respiratory aging optimization.
Indications
- Chronic obstructive pulmonary disease (COPD) support
- Lung tissue repair and regeneration
- Respiratory function optimization in aging
- Post-pneumonia recovery
- Bronchial asthma supportive therapy
- Environmental lung damage (pollution, smoking)
- Athletic pulmonary performance enhancement
Mechanism of Action
Chronic lung disease, age-related pulmonary decline, or environmental respiratory damage
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Chonluten | 20 mg | Once daily | Maintenance for respiratory health |
| Chonluten | 20 mg | Twice daily for first month, then once daily | For COPD or chronic pulmonary conditions |
Safety & Contraindications
- Emerging evidence - Russian clinical experience
- No toxic reactions reported in available studies
- Generally safe for long-term respiratory support
- Not a replacement for bronchodilators or emergency inhalers
- Consult physician with active lung infections or severe pulmonary disease
- Monitor respiratory function during use